To the full analysis
Eramet S.a. stock: growth
ERA.PAEramet S.a. reported $3.05B in revenue for fiscal 2025, down 6.1% on the prior year, down 0.4% a year on average over up to five years.
Daily figure as of 13 Nov 2026
Revenue (Annual rate)
−0.5%
per year from 2006 to 2025, per share −1.1%
Earnings (Annual rate)
no data
Free cash flow (Annual rate)
no data
Growth per year by period
What reaches shareholders is growth per share: buybacks lift it, new shares dilute it.
| since 2020 | since 2015 | since 2006 | |
|---|---|---|---|
| Revenue | −0.4% | −0.9% | −0.5% |
| Revenue per share | −1.9% | −1.7% | −1.1% |
| Earnings | no data | no data | no data |
| Earnings per share | no data | no data | no data |
| Free cash flow | no data | no data | no data |
| Free cash flow per share | no data | no data | no data |
Fiscal years at a glance
How revenue and earnings grow
- Revenue
- Earnings
- Free cash flow
Figures as a table
| Year | Revenue | Earnings | Free cash flow |
|---|---|---|---|
| 2006 | $3.39B | $353.48M | $254.86M |
| 2007 | $4.2B | $901.99M | $1.09B |
| 2008 | $4.82B | $947.43M | $1.26B |
| 2009 | $2.98B | −$289.21M | $124.11M |
| 2010 | $3.96B | $503.08M | $457.65M |
| 2011 | $3.99B | $335.75M | $654.89M |
| 2012 | $3.86B | $8.86M | −$485.35M |
| 2013 | $3.42B | −$410M | −$226.05M |
| 2014 | $3.41B | −$176.19M | −$294.75M |
| 2015 | $3.34B | −$791.18M | −$265.94M |
| 2016 | $3.27B | −$198.35M | −$126.32M |
| 2017 | $3.94B | $224.94M | $499.75M |
| 2018 | $4.15B | $58.73M | $152.92M |
| 2019 | $4.07B | −$203.89M | −$374.54M |
| 2020 | $3.12B | −$747.97M | −$4.43M |
| 2021 | $4.11B | $330.21M | $510.83M |
| 2022 | $5.56B | $819.99M | $474.27M |
| 2023 | $3.7B | $120.78M | −$468.73M |
| 2024 | $3.25B | $15.51M | −$899.78M |
| 2025 | $3.05B | −$528.56M | −$869.86M |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Currency
- Amounts in US dollars, converted at the ECB reference rate of 12 Nov 2026 ($1 = €0.9024)
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Weak, published since 7 Nov 2026 (in the score history since 30 Sep 2023)
- Valuation signal Overvalued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.